CBP issues updated Section 232 guidance on pharmaceutical imports under Proclamation 11020
CSMS # 70054007 - UPDATED GUIDANCE: Section 232 Duties on Imports of Pharmaceutical Articles and Ingredients
CBP states in CSMS # 70054007 that updated guidance covers Section 232 duties on pharmaceutical articles and ingredients under Proclamation 11020 and the September 23, 2026 Federal Register notice (91 FR 60360), with duties effective July 31, 2026 for Annex III companies and September 29, 2026 for all other companies. Entries use HTSUS headings 9903.04.60–9903.04.70, including 100% for patented articles under 9903.04.60, 15% for Japan, EU member countries, South Korea, Switzerland and Liechtenstein under 9903.04.62, and 0% for the United Kingdom under 9903.04.63. The notice makes five technical corrections to Annex I and one to Annex IV, removing 2937.23.50, 3002.13.00, 3002.14.00, 3002.15.00 and 3004.49.00 from Annex IV.
Importers of pharmaceuticals and ingredients from all countries must file under the 9903.04.60–9903.04.70 headings, with the lowest applicable rate applying when a product is subject to more than one rate.
Source: CBP · CSMS · content.govdelivery.com